Abstract
Only few antiviral substances have been licensed and/or are widely available for medical use. These include, at present, amantadine and rimantadine for the prophylaxis and early treatment of influenza A virus infections, idoxuridine, trifluridine, vidarabine and acyclovir for the topical treatment of herpetic keratitis, acyclovir for the systemic (intravenous or peroral) treatment of herpes simplex virus (HSV) and varicella-zoster virus (VZV) infections, vidarabine for the systemic (intravenous) treatment of herpetic encephalitis (although acyclovir is superior to vidarabine in the treatment of herpetic encephalitis), ribavirin for the topical (aerosol) treatment of respiratory syncytial virus infection in infants, and retrovir (azidothymidine) for the systemic (intravenous or peroral) treatment of AIDS and AIDS-related complex (ARC).1
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
